Navigation Links
CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries

nt and will consult with international experts to evaluate next steps."

FORWARD LOOKING STATEMENT

The materials in this presentation speak only as of the date of these materials, and include forward looking statements about our financial results and estimates, business prospects and products in research that involve substantial risks and uncertainties, many of which are outside the control of, and are unknown to, CSL. You can identify these statements by the fact that they use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," "target," "may," "assume," and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Among the factors that could cause actual results to differ materially are the following: the success of research and development activities, decisions by regulatory authorities regarding whether and when to approve our drug applications as well as their decisions regarding labeling and other matters that would affect the commercial potential of our products; competitive developments affecting our current growth products; the ability to successfully market new and existing products in Australia and other countries; difficulties or delays in manufacturing; trade buying patterns, fluctuations in interest and currency exchange rates; legislation or regulations throughout the world that affect product production, distribution, pricing, reimbursement or access; legal defense costs, insurance expenses, settlement costs and the risk of an adverse decision or settlement relating to product liability, patent protection or governmental investigations, growth in costs and expenses; and CSL's ability to protect its patents and other intellectual property throughout the world. The statements being made in this presentation do not constitute an offer to sell, or solicitation of an offer to buy, any securities of CSL.

CSL is a global specialty biopha
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
7. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
8. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
9. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
10. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
(Date:12/1/2008)...icy , , ROCHESTER, Minn., Dec. 1 /PRNewswi...ds the use of the drug therapy etanercept ineffect...ammation of the liver caused by excessive consumpt...shed in the December issue of Gastroenterology (...O ALERT: Additional audio and video resources, inc...
(Date:12/1/2008)...ay, December 9 at 11:00 am ET to Discuss Phase 2 S...ISCO, Calif., Dec. 1 S...biopharmaceutical company focused on the developme...ics, today announced new data from its studies of ...presented during the 50th American Society of Hema...
(Date:11/30/2008)...e-USNewswire/ -- Older adults who exercise regular...r number of small blood vessels in the brain, acco...eting of the Radiological Society of North America...University of North Carolina ( UNC) - Chapel Hill...ults who exercise to brain scans of those who do n...
(Date:11/28/2008)...tCall/ -- Eli Lilly and Company,(NYSE: LLY ) ha...(sNDA) from,the U.S. Food and Drug Administration...anagement of chronic pain. Lilly plans to resubmit...g data from a recently completed positive study,i... The decision does not affect duloxetine,s FDA-ap...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Barr Announces Approval of Generic Yasmin 28R 29 5282 1Barr Announces Approval of Generic Yasmin 28R 29 5282 2Barr Announces Approval of Generic Yasmin 28R 29 5282 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 1New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 5New Class of Drugs Might Treat Many Conditions 18938 1New Class of Drugs Might Treat Many Conditions 18938 2Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 1Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 2Kiwa Bio Tech 1st Quarter Revenues Increase 57 8 25 242 18 Million 5279 3
...e Skeletal Muscle More,Efficiently than Male Cells...e stem cells,derived from muscle have a greater ab...le cells, according to a study at Children,s,Hospi...eing published in the April 9 issue of the,Journal...fference,in regenerative capabilities of muscle st...
...007 - Inotek,Pharmaceuticals Corporation announced...eclinical animal data showing that the,administrat...tor,has a large protective effect on the survival ... a nuclear enzyme that directs the,repair of damag...epair enzymes and has potential applications for t...
Other Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 2Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 3
(Date:12/2/2008)... Fellow occupants can help keep driving safe, rese...y News) -- Drivers talking on a cell phone are mor...were speaking with a friend sitting next to them i...s basically a process of joint attention, so when ...ienced as a driver, that person actually understan...
(Date:12/2/2008)... With new naming structure, Kessler Foundation con...disabilities , , WEST ORANGE, N.J.Dec. 2 /P...rting people with physical disabilities, Henry H. ...on,s new name -- Kessler Foundation. The Foundatio...ions to Kessler Foundation Research Center and Kes...
(Date:12/2/2008)... -Survey Reveals Nearly Half Have Skipped Medical ..., Dec. 2 A new survey r...rce Center (NWHRC) highlights another troubling as...ave failed to seek health care for themselves or t...te that many women say their health has gotten wor...
(Date:12/2/2008)... At Least 10 New Cellular Therapies Will Launch Ov...ision Resources , , WALTHAM, Mass., Dec. 2 ...ld,s leading research and advisory firms for pharm...llular therapies drug market will experience robus..., reaching $1.5 billion in 2017. According to the ...
Breaking Medicine News(10 mins):Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 2Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 3Health News:Henry H. Kessler Foundation Rebranded as Kessler Foundation 2Health News:Henry H. Kessler Foundation Rebranded as Kessler Foundation 3Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4Health News:Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017 2
...(SAD) is not all that well understood, but is beli...inter months. Winter depression involves suffering...he days get longer and nights get shorter. Other S...h carbohydrate foods, and sleeping for longer than...
...a patient, a two-month-old baby with white blood! ...ase caused due to a deficiency of lipoprotein lipa...ion children. Doctors said that the baby was broug...ool. On detection the baby, a boy child, was found...
...olet rays, has always been said to be bad for one'... has shown that even moderate sun exposure can res...eadliest form of skin cancer. Exposure to sun has ...r, but the link between sun exposure and melanoma,...
... there is a metabolic threshold that occurs in you...tivity becomes deleterious for lumbar bone mineral...he researchers, over a 10-year period, investigate...sical activity and LBMD in 225 men and 241 women. ...
Other Medicine News:
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
Small, comes in a compact carrying case, carrying pouch included.
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure.
Medicine Products: